{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:06:40Z","timestamp":1761512800028},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T00:00:00Z","timestamp":1271462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10067-010-1457-8","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T05:02:36Z","timestamp":1271394156000},"page":"835-840","source":"Crossref","is-referenced-by-count":39,"title":["International position paper on febuxostat"],"prefix":"10.1007","volume":"29","author":[{"given":"Tim L.","family":"Jansen","sequence":"first","affiliation":[]},{"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Perez-Ruiz","sequence":"additional","affiliation":[]},{"given":"Anne-Kathrin","family":"Tausche","sequence":"additional","affiliation":[]},{"given":"Philip-Andr\u00e9","family":"Guerne","sequence":"additional","affiliation":[]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[]},{"given":"Burkhard","family":"Leeb","sequence":"additional","affiliation":[]},{"given":"Victoria","family":"Barskova","sequence":"additional","affiliation":[]},{"given":"Till","family":"Uhlig","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Piment\u00e3o","sequence":"additional","affiliation":[]},{"given":"Irena","family":"Zimmermann-G\u00f3rska","sequence":"additional","affiliation":[]},{"given":"Elisio","family":"Pascual","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Bardin","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Doherty","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,4,17]]},"reference":[{"key":"1457_CR1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.bor.0000162060.25895.a5","volume":"17","author":"RL Wortmann","year":"2005","unstructured":"Wortmann RL (2005) Recent advances in the management of gout and hyperuricemia. Curr Opin Rheumatol 17:319\u2013324","journal-title":"Curr Opin Rheumatol"},{"key":"1457_CR2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 65:1301\u20131311","journal-title":"Ann Rheum Dis"},{"key":"1457_CR3","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324","journal-title":"Ann Rheum Dis"},{"key":"1457_CR4","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2008","unstructured":"Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G (2008) British society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology 46:1372\u20131374","journal-title":"Rheumatology"},{"key":"1457_CR5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2007.078469","volume":"66","author":"E Pascual","year":"2007","unstructured":"Pascual E, Sivera F (2007) Why is gout so poorly managed? Ann Rheum Dis 66:1269\u20131270","journal-title":"Ann Rheum Dis"},{"key":"1457_CR6","unstructured":"CHMP assessment report for Adenuric\/febuxostat. Doc. ref. EMEA\/258531\/2008"},{"key":"1457_CR7","doi-asserted-by":"crossref","first-page":"ii9","DOI":"10.1093\/rheumatology\/kep087","volume":"48","author":"F Perez-Ruiz","year":"2009","unstructured":"Perez-Ruiz F (2009) Treating to target: a strategy to cure gout. Rheumatology 48:ii9\u2013ii14","journal-title":"Rheumatology"},{"key":"1457_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","volume":"68","author":"MK Reinders","year":"2009","unstructured":"Reinders MK, Van Roon EN, Jansen TLThA, Delsing J, Griep EN, Hoekstra M, Van de Laar MAFJ, Brouwers JRBJ (2009) Efficacy and tolerability of urate lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Ann Rheum Dis 68:51\u201356","journal-title":"Ann Rheum Dis"},{"key":"1457_CR9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/ard.2008.091462","volume":"68","author":"MK Reinders","year":"2009","unstructured":"Reinders MK, Haagsma C, Jansen TLThA, Van Roon EN, Delsing J, Van de Laar MAFJ, Brouwers JRBJ (2009) A randomized controlled trial with dose escalation on the efficacy and tolerability of allopurinol 300\u2013600\u00a0mg\/day versus benzbromarone 100\u2013200\u00a0mg\/day in gout patients. Ann Rheum Dis 68:892\u2013897","journal-title":"Ann Rheum Dis"},{"key":"1457_CR10","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR, Wortmann RL et al (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353:2450\u20132461","journal-title":"N Engl J Med"},{"key":"1457_CR11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","volume":"59","author":"HR Schumacher","year":"2008","unstructured":"Schumacher HR, Becker MA, Wortmann RL et al (2008) Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Care Res 59:1540\u20131548","journal-title":"Arthritis Care Res"},{"key":"1457_CR12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","volume":"52","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR, Wortmann RL et al (2005) Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum 52:916\u2013923","journal-title":"Arthritis Rheum"},{"key":"1457_CR13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","volume":"48","author":"HR Schumacher","year":"2009","unstructured":"Schumacher HR, Becker MA, Lloyd E, MacDonald PA, Lademacher C (2009) Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology 48:188\u2013194","journal-title":"Rheumatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1457-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1457-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1457-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:41Z","timestamp":1559119901000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1457-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,17]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1457-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,17]]}}}